Dalsgaard T, Kroigaard C, Misfeldt M, Bek T, Simonsen U
Department of Pharmacology, Aarhus University, Aarhus C, Denmark.
Br J Pharmacol. 2010 Jul;160(6):1496-508. doi: 10.1111/j.1476-5381.2010.00803.x.
Small (SK(Ca) or K(Ca)2) and intermediate (IK(Ca) or K(Ca)3.1) conductance calcium-activated potassium channels are involved in regulation of vascular tone and blood pressure. The present study investigated whether NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime) and CyPPA (cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine), which are selective openers of SK(Ca) and IK(Ca) channels and of SK(Ca)2 and SK(Ca)3 channels, respectively, enhance endothelium-dependent vasodilatation in porcine retinal arterioles.
In porcine retinal arterioles, SK(Ca)3 and IK(Ca) protein localization was examined by immunolabelling. Endothelial cell calcium was measured by fluorescence imaging. For functional studies, arterioles with internal diameters of 116 +/- 2 microm (n = 276) were mounted in microvascular myographs for isometric tension recordings.
SK(Ca)3 and IK(Ca) protein was localized in the endothelium. Bradykinin, but not NS309 or CyPPA increased endothelial cell calcium. Pre-incubation with NS309 or CyPPA enhanced bradykinin relaxation without changing endothelial cell calcium. This enhanced relaxation was abolished by blocking SK(Ca) channels with apamin. In the presence of NS309 or CyPPA, mainly inhibition of NO synthase with asymmetric dimethylarginine, but also inhibition of cyclooxygenase with indomethacin, reduced bradykinin relaxation. Bradykinin relaxation was completely abolished by NO synthase and cyclooxygenase inhibition together with a NO scavenger, oxyhaemoglobin.
In porcine retinal arterioles, bradykinin increases endothelial cell calcium leading to activation of SK(Ca) and IK(Ca) channels. Without altering endothelial cell calcium, NS309 and CyPPA open SK(Ca) channels that enhance NO-mediated bradykinin relaxations. These results imply that opening SK(Ca) channels improves endothelium-dependent relaxation and makes this channel a potential target for treatments aimed at restoring retinal blood flow.
小电导(SK(Ca)或K(Ca)2)和中电导(IK(Ca)或K(Ca)3.1)钙激活钾通道参与血管张力和血压的调节。本研究调查了分别作为SK(Ca)和IK(Ca)通道以及SK(Ca)2和SK(Ca)3通道选择性开放剂的NS309(6,7 - 二氯 - 1H - 吲哚 - 2,3 - 二酮3 - 肟)和CyPPA(环己基 - [2 - (3,5 - 二甲基 - 吡唑 - 1 - 基)-6 - 甲基 - 嘧啶 - 4 - 基]-胺)是否能增强猪视网膜小动脉的内皮依赖性血管舒张。
在猪视网膜小动脉中,通过免疫标记检测SK(Ca)3和IK(Ca)蛋白的定位。通过荧光成像测量内皮细胞钙。对于功能研究,将内径为116±2微米(n = 276)的小动脉安装在微血管肌动描记器中进行等长张力记录。
SK(Ca)3和IK(Ca)蛋白定位于内皮。缓激肽可增加内皮细胞钙,但NS309或CyPPA则不能。预先用NS309或CyPPA孵育可增强缓激肽诱导的舒张,而不改变内皮细胞钙。用蜂毒明肽阻断SK(Ca)通道可消除这种增强的舒张作用。在存在NS309或CyPPA的情况下,主要用不对称二甲基精氨酸抑制一氧化氮合酶,但也用吲哚美辛抑制环氧化酶,均可降低缓激肽诱导的舒张。一氧化氮合酶和环氧化酶抑制以及一氧化氮清除剂氧合血红蛋白共同作用可完全消除缓激肽诱导的舒张。
在猪视网膜小动脉中,缓激肽增加内皮细胞钙,导致SK(Ca)和IK(Ca)通道激活。NS309和CyPPA在不改变内皮细胞钙的情况下开放SK(Ca)通道,增强一氧化氮介导的缓激肽舒张作用。这些结果表明,开放SK(Ca)通道可改善内皮依赖性舒张,并使该通道成为旨在恢复视网膜血流治疗的潜在靶点。